Johnson & JohnsonJNJNYSE
Loading

Analyst Sentiment

Analysts lean bullish — 58% recommend buying.

Consensus Rating
Buy
24 analysts·High coverage
58%
Rating Distribution
Strong Buy
00%
Buy
1458%
Hold
1042%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Feb 3, 2026RBC Capital
Johnson & Johnson price target raised to $255 from $240 at RBC Capital
Target:$255.00
+9.3%from $233.35
Jan 28, 2026Morgan Stanley
Morgan Stanley Upgrades Johnson & Johnson (JNJ) to Overweight
Target:$262.00
+16.7%from $224.44
Jan 27, 2026Loop Capital Markets
Johnson & Johnson (JNJ) PT Raised to $220 at Freedom Capital Markets
Target:$220.00
-2.3%from $225.16
Jan 23, 2026Guggenheim
Johnson & Johnson price target raised to $240 from $227 at Guggenheim
Target:$240.00
+9.8%from $218.49
Jan 22, 2026Scotiabank
Johnson & Johnson price target raised to $265 from $230 at Scotiabank
Target:$265.00
+20.4%from $220.18
Jan 22, 2026Morgan Stanley
Johnson & Johnson price target raised to $200 from $197 at Morgan Stanley
Target:$200.00
-9.2%from $220.37
Jan 22, 2026Stifel Nicolaus
Johnson & Johnson price target raised to $220 from $205 at Stifel
Target:$220.00
+0.9%from $218.01
Jan 22, 2026Goldman Sachs
Johnson & Johnson price target raised to $250 from $240 at Goldman Sachs
Target:$250.00
+14.7%from $218.01
Jan 22, 2026Wells Fargo
Johnson & Johnson price target raised to $240 from $230 at Wells Fargo
Target:$240.00
+10.1%from $218.01
Jan 9, 2026Bernstein
Johnson & Johnson price target raised to $208 from $193 at Bernstein
Target:$208.00
+1.1%from $205.75
Dec 30, 2025Barclays
Johnson & Johnson (JNJ) PT Raised to $217 at Barclays
Target:$217.00
+4.5%from $207.56
Dec 18, 2025Goldman Sachs
Johnson & Johnson price target raised to $240 from $213 at Goldman Sachs
Target:$240.00
+14.1%from $210.33
Dec 17, 2025RBC Capital
Johnson & Johnson price target raised to $240 from $230 at RBC Capital
Target:$240.00
+14.8%from $209.07
Dec 12, 2025Morgan Stanley
Johnson & Johnson price target raised to $197 from $190 at Morgan Stanley
Target:$197.00
-6.5%from $210.60
Dec 11, 2025RBC Capital
Johnson & Johnson price target raised to $230 from $209 at RBC Capital
Target:$230.00
+11.4%from $206.54
Dec 10, 2025HSBC
Johnson & Johnson price target raised to $240 from $215 at HSBC
Target:$240.00
+20.0%from $199.96
Dec 5, 2025Guggenheim
Johnson & Johnson price target raised to $227 from $206 at Guggenheim
Target:$227.00
+12.1%from $202.48
Dec 2, 2025Barclays
Johnson & Johnson price target raised to $197 from $176 at Barclays
Target:$197.00
-4.1%from $205.34
Oct 22, 2025Johnson Rice
Johnson & Johnson downgraded to Hold from Buy at Freedom Capital
Target:$190.00
-1.6%from $193.18
Oct 22, 2025Loop Capital Markets
Freedom Capital Markets Downgrades Johnson & Johnson (JNJ) to Hold
Target:$190.00
-1.6%from $193.18
Oct 15, 2025Argus Research
Johnson & Johnson price target raised to $210 from $185 at Argus
Target:$210.00
+9.8%from $191.19
Oct 15, 2025Raymond James
Johnson & Johnson price target raised to $209 from $174 at Raymond James
Target:$209.00
+9.5%from $190.85
Oct 15, 2025Morgan Stanley
Johnson & Johnson price target raised to $190 from $178 at Morgan Stanley
Target:$190.00
-0.4%from $190.85
Oct 15, 2025Stifel Nicolaus
Johnson & Johnson price target raised to $190 from $165 at Stifel
Target:$190.00
-0.4%from $190.85
Oct 14, 2025UBS
Johnson & Johnson price target raised to $214 from $190 at UBS
Target:$214.00
+14.3%from $187.22